全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

门静脉插管化疗预防大肠癌肝转移的临床应用

, PP. 391-392

Keywords: 大肠癌,门静脉,化疗

Full-Text   Cite this paper   Add to My Lib

Abstract:

为探讨一种合理的途径进行大肠癌术后化疗,预防肝转移,以提高大肠癌临床疗效,回顾分析2001年4月~2003年7月收治的14例中、晚期大肠癌患者采用术中经门静脉留置管,术后经此管进行化疗并观察其临床疗效。结果,全组无手术死亡,2例留置管堵塞,1例放弃术后化疗。全组病人1年随访率78.67%(11/14),1例肝转移,1例腹腔转移,1例吻合口瘘,其余未见明显异常;2年随访率42.80%(6/14),未见复发及转移病例,对中晚期大肠癌患者术中门静脉插管、术后经门静脉化疗,可有效地降低肝转移发生率,提高患者生存率。更多还原

References

[1]  Nakamura S,Suzuki Z. Resection of liver metastases of colorectal carcinoma[J]. World J Surg,1997,21(7): 741-747.
[2]  Finlay IG,Meck D,Brunten F,et al. Grouth rate of hepatic watastases in colorectal carcinoma[J]. Br J Surg,1998,75:641.
[3]  张 森.结直肠癌肝转移与肝脏免疫功能[J].大肠肛门病外科杂志,2003,9(2 ):131-133.
[4]  Taylor I. Liver infusion metu-analysisgroup[J]. J Natl Cancer Inst ,1997,89:497-139.
[5]  Zaleberg JR,Siderow J,Simes J. On behalf of the Australasian Gast rointest inal Trials Group. The role of 5-fluorouracil dose in the adjuvant therapy of c olorectal cancer[J].Ann Oncol,1996,7:41.
[6]  Liver Infusion Meta-analysis Group. Portal vein chemotherapy for co lorectal cancer: a meta-analysis of 4000 patients in 10 studies[J]. J Natl Cancer Ins t,1997,89:497.
[7]  Wereldsma JC,Bruggink ED,Meijer WS,et al. Adjuvant portal liver infus ion in colorectal cancer with 5-fluorouracil/heparin versus urokinase versus contro l[J]. Cancer,1990,65:425.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133